Early Intra‐articular Hyaluronic Acid Injection After Anterior Cruciate Ligament Reconstruction Provides Short‐Term Pain Relief and Improves Early Postoperative Function With No Clinical Benefits at 6 and 12 Months: A Randomized Controlled Trial

医学 前交叉韧带重建术 透明质酸 随机对照试验 前交叉韧带 外科 止痛 麻醉 期限(时间) 解剖 量子力学 物理
作者
Raghavendra Balagod,Sujit Kumar Tripathy,Siddharth Satyakam Pradhan,Paulson Varghese,Mathan Kumar Ramasubbu,Anand Srinivasan,Gunjar Jain,Mantu Jain
出处
期刊:Arthroscopy [Wiley]
卷期号:41 (9): 3371-3381 被引量:3
标识
DOI:10.1016/j.arthro.2025.02.010
摘要

PURPOSE: To assess the safety and effectiveness of intra-articular hyaluronic acid (HA) when administered at various time points after arthroscopic anterior cruciate ligament reconstruction (ACLR) surgery. METHODS: Ninety patients with anterior cruciate ligament tears undergoing arthroscopic ACLR were divided into 1 of 3 groups: The early HA group received HA on day 2 and saline solution at 2 months, the late HA group received saline solution on day 2 and HA at 2 months, and the placebo group received saline solution at both times. Clinical variables (range of motion [ROM], knee circumference, Lysholm score, International Knee Documentation Committee [IKDC] score, visual analog scale [VAS] score, EQ-5D-5L [EuroQol 5-dimension 5-level questionnaire] score, and Tegner score) and blood parameters (erythrocyte sedimentation rate and C-reactive protein level) were assessed at baseline, monthly up to 6 months, and at 12 months. The synovial tumor necrosis factor α level was measured at baseline, on day 2, and at 3 months. RESULTS: The early HA group showed significantly better ROM than the placebo group (P = .041) and late HA group (P = .029) at 1 and 2 months after surgery. Pain was significantly lower in the early HA group at 1 month compared with the placebo group (P = .033). The early HA group achieved a faster median recovery time to a Lysholm score greater than 83 (P = .01) and had superior Lysholm scores at 2 months. In addition, EQ-5D-5L and IKDC scores were significantly better at 1 and 2 months in the early HA group. There were no differences in erythrocyte sedimentation rate and C-reactive protein level between the groups at any follow-up. However, both HA groups showed a significant decrease in tumor necrosis factor α level from baseline (P < .05). No adverse events were reported. The minimal clinically important difference (MCID) for the VAS score at 1 month was achieved by 93.3%, 60.7%, and 65.5% of participants in the early HA group, late HA group, and placebo group, respectively (P < .01). However, no significant differences were observed between the groups in the percentage of patients achieving the MCID for the VAS score at 1 year or the MCIDs for the IKDC and Lysholm scores at 1 month, 2 months, and 1 year. CONCLUSIONS: Early intra-articular HA injection after ACLR effectively reduced pain and improved ROM during the early postoperative period, leading to enhanced functional outcomes and quality of life. However, these benefits were not sustained beyond 2 months, and no clinical benefits were noted at 6- and 12-month follow-up. The treatment was found to be safe and well tolerated for postoperative use. Notably, there was no significant difference in the number of patients achieving the MCIDs for functional scores, except for pain at 1 month. LEVEL OF EVIDENCE: Level I, double-blind randomized controlled study.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小阿俊完成签到,获得积分10
刚刚
金金完成签到,获得积分10
刚刚
1秒前
情怀的应助被poi采纳,获得10
3秒前
Owen的应助被开心德地采纳,获得10
4秒前
6秒前
7秒前
7秒前
Orange的应助被yuko采纳,获得10
8秒前
Gjorv完成签到 ,获得积分10
8秒前
8秒前
顺顺利利的应助被meimei3313采纳,获得50
12秒前
molihuakai的应助被开心德地采纳,获得10
12秒前
科研通AI65的应助被神棍喜来乐采纳,获得10
13秒前
XR发布了新的文献求助10
13秒前
13秒前
烟花的应助被xuhang采纳,获得10
14秒前
我是老大的应助被jiajia采纳,获得10
16秒前
娜娜子欧完成签到,获得积分10
16秒前
赘婿的应助被wg采纳,获得10
17秒前
内向的语雪完成签到,获得积分10
18秒前
arniu2008的应助被唐宇航采纳,获得80
18秒前
dingyang41发布了新的文献求助10
18秒前
hbkj完成签到,获得积分10
19秒前
19秒前
舟舟完成签到 ,获得积分0
20秒前
斯文若云完成签到 ,获得积分10
20秒前
共享精神的应助被开心德地采纳,获得10
20秒前
科研通AI65的应助被Sephirex采纳,获得10
22秒前
22秒前
22秒前
poi完成签到,获得积分10
22秒前
成就忻完成签到,获得积分10
24秒前
HRsd完成签到 ,获得积分10
24秒前
Gc完成签到,获得积分10
24秒前
25秒前
25秒前
隐形曼青的应助被陈向洋采纳,获得10
25秒前
lobster发布了新的文献求助10
26秒前
SciGPT的应助被odd采纳,获得10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188885
求助须知:如何正确求助?哪些是违规求助? 9576442
关于积分的说明 21847777
捐赠科研通 7786897
什么是DOI,文献DOI怎么找? 3435446
关于科研通互助平台的介绍 2559654
邀请新用户注册赠送积分活动 2482383